STOCK TITAN

Genfit S.A. SEC Filings

GNFT NASDAQ

Welcome to our dedicated page for Genfit S.A. SEC filings (Ticker: GNFT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genfit S.A.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genfit S.A.'s regulatory disclosures and financial reporting.

Rhea-AI Summary

Foundations Investment Advisors, LLC (FIA) has filed Amendment No. 5 to its Schedule 13G for the Hypatia Women CEO ETF (CUSIP 90214Q527), a series of the Two Roads Shared Trust. The filing, triggered as of 30 June 2025 and signed on 8 July 2025, discloses that FIA now reports zero shares beneficially owned, representing 0% of the outstanding class. FIA also reports no sole or shared voting or dispositive power over any shares.

Because beneficial ownership has fallen below the 5 % reporting threshold, FIA checks the box for “Ownership of 5 percent or less of a class” and lists itself under Item 3(e) as an investment adviser registered under Rule 13d-1(b)(1)(ii)(E).

The absence of any remaining position suggests a complete exit or reclassification of shares previously held. No other entities are listed, and there is no indication of group activity, subsidiary involvement, or pending transactions. Certifications are routine and the document contains no financial statements or earnings data.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Genfit S.A. (GNFT)?

The current stock price of Genfit S.A. (GNFT) is $3.79 as of July 18, 2025.

What is the market cap of Genfit S.A. (GNFT)?

The market cap of Genfit S.A. (GNFT) is approximately 187.5M.
Genfit S.A.

NASDAQ:GNFT

GNFT Rankings

GNFT Stock Data

187.51M
50.00M
0.52%
0.11%
Biotechnology
Healthcare
Link
France
Loos